HIGHLIGHTS
- who: Pantea Kiani et al. from the Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, CG Utrecht, The Netherlands have published the Article: Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies, in the Journal: (JOURNAL)
- what: Undesirable side effects of the vaccination are commonly experienced and comprise one of the primary reasons for a substantial group of individuals to refrain from vaccination.
- future: More research is needed to elucidate the mechanistic pathways that may explain the efficacy and safety of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.